BOSTON , Oct. 24, 2012 /PRNewswire/ -- Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased to announce that the Company's manufacturer of introducers, dilators and cytology retrieval kits has retained a medical testing facility in order to verify an increase in the sterilization expiration date for the disposable instruments that are part of the MammoView® Breast Endoscopy product line. Currently, the MammoView® Breast Endoscopy disposables have a one year expiration date; the Company is now testing in order to give the products a two year expiration date.

Solos Endoscopy MammoView® Instruments are already FDA approved, however, by increasing the sterilization life to two years, the Company will be able to carry more inventory and ultimately increase sales as hospitals can be more confident in ordering larger quantities.

"Management expects that this improvement will benefit everyone, from the hospitals to the shareholders. The Company's ability to manufacture and carry more inventory will improve our margins, and give our customers greater confidence when ordering larger quantities of our disposable product line," stated Solos Endoscopy CEO, Robert Segersten .

Solos Endoscopy retained TUV SUD America, Inc. to complete its ISO 13485 Certification and Audit on its instruments including the MammoView®. The Company previously engaged Expert Resource to prepare the Company for the final audit. Expert Resource will attend the final audit, and help interpret any findings. According to Expert Resource, their consultants maintain a 100% success rate of passing the final audit on the first attempt. Solos Endoscopy has posted its updated ISO 13485 CE Mark Schedule on its website, http://solosendoscopy.com/pdf/SNDY-ISO-13485-...r-2012.pdf .